Servier ends MMPI deal with ConjuChem

ConjuChem (TSE:CJC) said Laboratoires Servier (Paris, France) will not exercise its option to proceed with clinical development of a matrix metalloproteinase inhibitor (MMPI) anticancer compound, whic...